81 FR 57924 - Agency Information Collection Activities; Proposed Collection; Public Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary

Federal Register Volume 81, Issue 164 (August 24, 2016)

Page Range		57924-57925
FR Document		2016-20158

In compliance with section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). The ICR is for extension of the approved information collection assigned OMB control number OS-0990-0323, which expires on January 31, 2017. Prior to submitting the ICR to OMB, OS seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.

Federal Register, Volume 81 Issue 164 (Wednesday, August 24, 2016)

[Federal Register Volume 81, Number 164 (Wednesday, August 24, 2016)]
[Notices]
[Pages 57924-57925]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20158]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

[Document Identifier: HHS-OS-0990-0323-60D]


Agency Information Collection Activities; Proposed Collection; 
Public Comment Request

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995, the Office of the Secretary (OS), Department of 
Health and Human Services, announces plans to submit an Information 
Collection Request (ICR), described below, to the Office of Management 
and Budget (OMB). The ICR is for extension of the approved information 
collection assigned OMB control number OS-0990-0323, which expires on 
January 31, 2017. Prior to submitting the ICR to OMB, OS seeks comments 
from the public regarding the burden estimate, below, or any other 
aspect of the ICR.

DATES: Comments on the ICR must be received on or before October 24, 
2016.

ADDRESSES: Submit your comments to 
[email protected] or by calling (202) 690-6162.

FOR FURTHER INFORMATION CONTACT: Information Collection Clearance 
staff, [email protected] or (202) 690-6162.

SUPPLEMENTARY INFORMATION: When submitting comments or requesting 
information, please include the document identifier HHS-OS-0990-0323-
60D for reference.
    Information Collection Request Title: Medical Countermeasures.gov.
    Abstract: In order to route product developers to the most 
appropriate personnel within the Department of Health and Human 
Services (HHS), HHS collects some basic information about the company's 
product through Medical Countermeasures.gov. Using this information and 
a routing system that has been developed with input from participating 
agencies within HHS, including the Office of the Assistant Secretary 
for Preparedness and Response (ASPR), the Centers for Disease Control 
and Prevention (CDC), the Food and Drug Administration (FDA), and the 
National Institutes of Health (NIH), Medical Countermeasures.gov routes 
the meeting request to the appropriate person within HHS. ASPR is 
requesting an extension by OMB for a three-year clearance.
    Need and Proposed Use of the Information: Meeting Request Routing 
System for Medical Countermeasures.gov--OMB No. 0990-0323--Extension--
Office of the Assistant Secretary for Preparedness and Response (ASPR), 
Office of the Biomedical Advanced Research and Development Authority 
(BARDA).
    Likely Respondents: Medical Countermeasure Developers.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions, to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information, to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information, and to transmit or otherwise 
disclose the information. The total annual burden hours estimated for 
this ICR are summarized in the table below.

                                    Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
                    Form name                       respondents    responses per   response  (in       hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Meeting Request.................................             225               1            8/60              30
                                                 ---------------------------------------------------------------
    Total.......................................             225               1            8/60              30
----------------------------------------------------------------------------------------------------------------


[[Page 57925]]

    OS specifically requests comments on (1) the necessity and utility 
of the proposed information collection for the proper performance of 
the agency's functions, (2) the accuracy of the estimated burden, (3) 
ways to enhance the quality, utility, and clarity of the information to 
be collected, and (4) the use of automated collection techniques or 
other forms of information technology to minimize the information 
collection burden.

Terry S. Clark,
Asst Information Collection Clearance Officer.
[FR Doc. 2016-20158 Filed 8-23-16; 8:45 am]
 BILLING CODE 4150-37-P

Federal Register / Vol. 81, No. 164 / Wednesday, August 24, 2016 / Notices 57925

OS specifically requests comments on Infertility Loan Repayment Program, National 93.337, 93.393–93.396, 93.837–93.844,
(1) the necessity and utility of the Institutes of Health, HHS) 93.846–93.878, 93.892, 93.893, National
proposed information collection for the Institutes of Health, HHS)
Dated: August 18, 2016.
proper performance of the agency’s Dated: August 17, 2016.
Michelle Trout,
functions, (2) the accuracy of the David Clary,
estimated burden, (3) ways to enhance Program Analyst, Office of Federal Advisory
Committee Policy. Program Analyst, Office of Federal Advisory
the quality, utility, and clarity of the Committee Policy.
[FR Doc. 2016–20150 Filed 8–23–16; 8:45 am]
information to be collected, and (4) the [FR Doc. 2016–20151 Filed 8–23–16; 8:45 am]
use of automated collection techniques BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
or other forms of information
technology to minimize the information
DEPARTMENT OF HEALTH AND
collection burden. DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Terry S. Clark, HUMAN SERVICES
Asst Information Collection Clearance National Institutes of Health
National Institutes of Health
Officer.
Center For Scientific Review; Notice of
[FR Doc. 2016–20158 Filed 8–23–16; 8:45 am] Government-Owned Inventions;
Closed Meetings
BILLING CODE 4150–37–P Availability for Licensing
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as AGENCY: National Institutes of Health,
DEPARTMENT OF HEALTH AND amended (5 U.S.C. App.), notice is HHS.
HUMAN SERVICES hereby given of the following meetings. ACTION: Notice.
The meetings will be closed to the
National Institutes of Health SUMMARY: The invention listed below is
public in accordance with the
owned by an agency of the U.S.
provisions set forth in sections
Eunice Kennedy Shriver National Government and is available for
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Institute of Child Health & Human licensing and/or co-development in the
as amended. The grant applications and
Development; Notice of Closed U.S. in accordance with 35 U.S.C. 209
the discussions could disclose
Meeting and 37 CFR part 404 to achieve
confidential trade secrets or commercial
expeditious commercialization of
Pursuant to section 10(d) of the property such as patentable material,
results of federally-funded research and
Federal Advisory Committee Act, as and personal information concerning
development. Foreign patent
amended (5 U.S.C. App.), notice is individuals associated with the grant
applications are filed on selected
hereby given of the following meeting. applications, the disclosure of which
inventions to extend market coverage
The meeting will be closed to the would constitute a clearly unwarranted
for companies and may also be available
public in accordance with the invasion of personal privacy.
for licensing and/or co-development.
provisions set forth in sections Name of Committee: Center for Scientific ADDRESSES: Invention Development and
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Review Special Emphasis Panel; Shared and
as amended. The grant applications and High-End Instrumentation: Crystallography
Marketing Unit, Technology Transfer
the discussions could disclose and NMR. Center, National Cancer Institute, 9609
confidential trade secrets or commercial Date: September 20, 2016. Medical Center Drive, Mail Stop 9702,
property such as patentable material, Time: 8:00 a.m. to 6:00 p.m. Rockville, MD 20850–9702.
Agenda: To review and evaluate grant FOR FURTHER INFORMATION CONTACT:
and personal information concerning
applications. Information on licensing and co-
individuals associated with the grant Place: National Institutes of Health, 6701
applications, the disclosure of which development research collaborations,
Rockledge Drive, Bethesda, MD 20892,
would constitute a clearly unwarranted (Telephone Conference Call).
and copies of the U.S. patent
invasion of personal privacy. Contact Person: Michael Eissenstat, Ph.D., applications listed below may be
Scientific Review Officer, BCMB IRG, Center obtained by contacting: Attn. Invention
Name of Committee: National Institute of
for Scientific Review, National Institutes of Development and Marketing Unit,
Child Health and Human Development
Special Emphasis Panel, Developmental Health, 6701 Rockledge Drive, Room 4166, Technology Transfer Center, National
Mechanisms of Human Structural Birth Bethesda, MD 20892, 301–435–1722, Cancer Institute, 9609 Medical Center
Defects. eissenstatma@csr.nih.gov. Drive, Mail Stop 9702, Rockville, MD
Date: September 20, 2016. Name of Committee: Center for Scientific 20850–9702, Tel. 240–276–5515 or
Time: 2:00 p.m. to 5:00 p.m. Review Special Emphasis Panel; Shared and email ncitechtransfer@mail.nih.gov. A
Agenda: To review and evaluate grant High-End Instrumentation: Crystallography signed Confidential Disclosure
applications. and NMR.
Date: September 20, 2016.
Agreement may be required to receive
Place: National Institutes of Health,
Time: 8:00 a.m. to 6:00 p.m. copies of the patent applications.
Rockledge 6710B, 6710B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Agenda: To review and evaluate grant SUPPLEMENTARY INFORMATION:
Call). applications. Technology description follows.
Contact Person: Sherry L Dupere, Ph.D., Place: National Institutes of Health, 6701 Title of invention: Processes for
Chief, Scientific Review Branch, Scientific Rockledge Drive, Bethesda, MD 20892, Producing and Purifying Nucleic Acid-
Review Branch, Eunice Kennedy Shriver (Virtual Meeting). Containing Compositions.
National Institute of Child Health and Contact Person: Sudha Veeraraghavan, Description of Technology: This
mstockstill on DSK3G9T082PROD with NOTICES

Human Development, NIH, 6710 B Rockledge Ph.D., Scientific Review Officer, Center for
technology consists of improved
Drive, Room 2115, Bethesda, MD 20892– Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD processes for producing and purifying
7510, 301–451–3415, duperes@mail.nih.gov.
(Catalogue of Federal Domestic Assistance 20892, 301–435–1504, nucleic acid-containing compositions,
Program Nos. 93.864, Population Research; sudha.veeraraghavan@nih.gov. such as non-naturally occurring viruses,
93.865, Research for Mothers and Children; (Catalogue of Federal Domestic Assistance for example, recombinant polioviruses
93.929, Center for Medical Rehabilitation Program Nos. 93.306, Comparative Medicine; that can be used as oncolytic agents.
Research; 93.209, Contraception and 93.333, Clinical Research, 93.306, 93.333, Some of the improved processes relate

VerDate Sep<11>2014 20:16 Aug 23, 2016 Jkt 238001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\24AUN1.SGM 24AUN1

Document Created: 2016-08-24 03:02:21
Document Modified: 2016-08-24 03:02:21

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Comments on the ICR must be received on or before October 24, 2016.
Contact		Information Collection Clearance staff, [email protected] or (202) 690-6162.
FR Citation		81 FR 57924

81 FR 57924 - Agency Information Collection Activities; Proposed Collection; Public Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICESOffice of the Secretary

Federal Register Volume 81, Issue 164 (August 24, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary